Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C10 - Myelin Oligodendrocyte Glycoprotein Antibody Disorders (MOGAD)

Saturday 04/13/24
12:00 PM - 02:00 PM MDT Add To Calendar
Colorado Convention Center | Mile High 1EF
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Brenda Banwell, MD, FAAN
Multiple Sclerosis
Participants will be presented with recently published international consensus diagnostic criteria for MOGAD, and details on laboratory testing for MOG-IgG. Clinical features, disease course, and current therapeutic strategies will be reviewed. MRI findings in MOGAD patients, as well as clues pointing towards other conditions in the differential of MOGAD, will be highlighted. Attendees will be provided an up-to-date review of the evolving landscape of MOGAD in both children and adults.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Advanced
Fellow, Resident, Specialist Neurologist, Advanced Practice Provider, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
12:00 PM - 12:05 PM MDT Introduction Welcome
Brenda Banwell, MD, FAAN
12:05 PM - 12:40 PM MDT Speaker Clinical Features and Diagnosis of MOGAD
Brenda Banwell, MD, FAAN
12:40 PM - 01:15 PM MDT Speaker Imaging Features of MOGAD and Key Flags
Giulia Fadda, MD
01:15 PM - 01:45 PM MDT Speaker Pathological Insights into MOGAD Biology: Clues for Etiology and Treatment
Romana Hoeftberger
01:45 PM - 02:00 PM MDT Discussion Panel and Audience Discussion on MOGAD: Future Directions
Brenda Banwell, MD, FAAN
Faculty Disclosures
Brenda Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Giulia Fadda, MD Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics.
Romana Hoeftberger Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun, Biogen, Sanofi-Aventis, and UCB Biopharma.